Uroplakin II
- Uroplakin II (UPII) and p40 antibodies are high specificity in urothelial carcinoma.
- Uroplakin II is a more sensitive immunohistochemical marker than uroplakin III in urothelial carcinoma.
- Its advantages in the differential diagnosis of urothelial carcinoma and in the detection of tumors of unknown origin.

DIAGNOSTIC BIOSYSTEMS
Since 1994, Diagnostic BioSystems Inc. has been committed to enhancing immunohistochemistry results by providing innovative anatomic pathology reagents and systems to improve the practice of pathology. Since our inception, our prime focus has been to provide high quality products and exceptional customer service and support. Read More >
Products by Category
EVENTS
Checkout latest events information.

D-I-Y HANDS ON IHC WORKSHOP
Do It Yourself, Diagnose It Yourself
Organized by Departments of Pathology & Oncopathology
DATE: 28th & 29th May 2022 | VIEW EVENT DETAILS >>
News & Blog Posts
Checkout our latest news articles, events info, campaigns and so on..
Global Health Exhibition 2025
Global Health Exhibition 2025! Dates: October 27–30, 2025 Location: Riyadh, Saudi Arabia..
Nov
Liver Cancer Awareness Month 2025
Liver Cancer Awareness Month Diagnostic BioSystems raises awareness on one of the..
Oct
Global Health Exhibition
Global Health Exhibition! #IHC #saudiarabia #LifeSciences Looking for Innovative and Global quality..
Oct
Breast Cancer Awareness Month 2025
Breast Cancer Awareness Month: Pioneering Detection with Precision At Diagnostic BioSystems, we..
Oct
Thyroid Cancer Awareness
Thyroid Cancer Awareness Thyroid nodules may be detected on physical examination..
Sep
Childhood Cancer Awareness
September is Childhood Cancer Awareness Month Every year, over 400,000 children around..
Sep
Appendix Cancer Awareness Month!
Appendix Cancer Awareness Month! Appendix is a small pouch of tissue in..
Aug
Not a Member? Join us!
Register your account today for exclusive offers, online ordering and access to a wealth of Dbiosys knowledge. Join us in the Fight Against Cancer Campaign, One Slide at a Time.


